Antibacterial Silver by Clement, Julia L. & Jarrett, Penelope S.
ANTIBACTERIAL SILVER
Julia L. Clement and Penelope S. Jarrett
School of Chemistry and Applied Chemistry, University of Wales College of Cardiff,
P.O. Box 912, Cardiff CF1 3TB, U.K.
The antibacterial activity of silver has long been known and has found a variety of applications
because its toxicity to human cells is considerably lower than to bacteria. The most widely
documented uses are prophylactic treatment of burns and water disinfection. However, the
mechanisms by which silver kills cells are not known. Information on resistance mechanisms is
apparently contradictory and even the chemistry of Ag+ in such systems is poorly understood.
Silver binds to many cellular components, with membrane components probably being more
important than nucleic acids. It is difficult to know whether strong binding reflects toxicity or
detoxification: some sensitive bacterial strains have been reported as accumulating more silver than
the corresponding resistant strain, in others the reverse apparently occurs. In several cases
resistance has been shown to be plasmid mediated. The plasmids are reported as difficult to
transfer, and can also be difficult to maintain, as we too have found. Attempts to find biochemical
differences between resistant and sensitive strains have met with limited success: differences are
subtle, such as increased cell surface hydrophobicity in a resistant Escherichia coil
Some of the problems are due to defining conditions in which resistance can be observed. Silver(I)
has been shown to bind to components of cell culture media, and the presence of chloride is
necessary to demonstrate resistance. The form of silver used must also be considered. This is
usually water soluble AgNO3, which readily precipitates as AgCI. The clinically preferred compound
is the highly insoluble silver sulfadiazine, which does not cause hypochloraemia in burns. It has
been suggested that resistant bacteria are those unable to bind Ag+ more tightly than does
chloride. It may be that certain forms of insoluble silver are taken up by cells, as has been found for
nickel. Under our experimental conditions, silver complexed by certain ligands is more cytotoxic than
AgNO3, yet with related ligands is considerably less toxic. There is evidently a subtle interplay of
solubility and stability which should reward further investigation.
Introduction
The antimicrobial activity of silver appears to have been known since early in recorded history.
Herodotus describes how the King of Persia, when going to war, among his provisions took boiled
water stored in flagons of silver (1,2). The first modern description of this effect was given by Raulin
in 1869, who observed that Aspergillus niger could not grow in silver vessels (3,4). He was
somewhat upstaged by the Swiss botanist von Ngeli (3,5) who devised the term "oligodynamic" to
describe any metal which exhibits bacteriocidal properties at minute concentrations ("oligos", small +
"dynamis", power). He was studying silver, and it is especially true of this metal, although copper and
tin also have oligodynamic activity. Von Ngeli distinguished between "oligodynamic" death, and
"ordinary" poisoning at measurable concentrations. This terminology seems to have contributed to
much confused thinking about the means and mechanism(s) by which silver kills bacteria, most of
which have been well documented by Romans (6), but the word "oligodynamic" still appears in quite
modern textbooks (7).
There are several more recent discussions of the biological activity and importance of silver from
different points of view (8-12).
Water Sterilization
The idea of oligodynamic activity has been behind the development of many antimicrobial processes
and products. One of the earliest and most studied was "Katadyn silver" (13), described as a spongy
preparation of metallic silver, containing a small amount of added palladium or gold. The intention
was to maximise the silver surface area and.thus the area in contact with the water. It has been used
to coat sand, the insides of flasks, or other materials, and to impregnate filters (14). The wide range
of reported activity for Katadyn silver (0.006 ppm-0.5 ppm) illustrates a major problem for those
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working with silver: the concentrations required for antibacterial effect are generally low and are very
dependent upon the conditions used. Some workers recognised the importance of the medium.
The activity of Katadyn rings is inhibited by the presence of organic matter and inorganic substances
(15), that of Katadyn flasks is inhibited by milk (16) and even Dresden tap waterwas less bacteriocidal
than distilled water containing the same concentration of silver(I) (17). The same workers (17) also
demonstrated the inhibitory effects of colloids, low temperature, and storage in glass containers.
Despite these problems and its relatively high cost, silver is still an attractive option for water
sterilization since it is active at low concentrations for long periods, is odourless and of extremely low
toxicity to humans. Various methods have been used to introduce silver ions into the water,
including direct addition of soluble silver(I) salts, inorganic composites and electrical methods such
as "Electro-Katadyn" (6). Popular applications are to drinking water (19) and swimming pools,
although Mailman (20) concluded that Electm-Katadyn was not an appropriate treatment since the
total bacterial counts were too high, despite finding that the numbers of E. coil were reduced
sufficiently and the remaining bacteda were not pathogenic. Silver is still promoted as a swimming
pool disinfectant. A recent suggestion is to combine electrolytically generated copper(I) and silver(I)
with a chlorine treatment, thereby reducing the concentration of irritating chlorine which needs to be
used (18).
Therapeutic ADDliCations
Silver nitrate was introduced by Credd in 1884 for the prevention of ophthalmia neonatorum, and
until recently most states of the USA required that a few drops of a 1% AgNO3 solution be instilled in
infants’ eyes immediately after birth for the same purpose (6). Simple silver(I) salts give rise to high
concentrations of Ag+ in solution, which is precipitated by chloride and proteins, giving rise to
astringent effects. This principle is applied in caustic silver nitrate pencils for the cauterization of
small wounds and removal of granulation tissue (21). Such effects, however, are usually undesirable
for an antibacterial agent and a vadety of colloidal preparations, including silver proteinate, were
developed, mainly for topical use (6,21). These have been Supplanted by other antibiotics.
Although Ag+ is locally astringent, silver is not poisonous to mammals. Romans (6) has summarised
much of the data. Excessive amounts of silver compounds or long term treatment with silver(I) (22)
can cause argyria. This is discolouration of the skin or tissues which is generally irreversible but does
not seem to be harmful. Indeed, a study of many cases could find no cellular reactions to the
deposited silver (23). AgNO3 does inhibit respiration of guinea-pig ear skin in tissue culture, but at
about 25 times the minimal concentration which killed Pseudomonas aeruginosa (60). Canadian
women were found to ingest 7.1 mg daily from their food, with no apparent ill-effect (24). Acute oral
toxicity ranges from 2 to 30g (8).
At present, the major therapeutic use of silver(I) is in the topical chemoprophylaxis of burns. Silver
nitrate had been used at high concentrations, but was reintroduced at lower concentration in 1965
(25). A controlled trial using compresses containing 0.5% silver nitrate on severely burned patients
showed its effective-,ess at preventing infection by Pseudomonas aeruginosa (76) and the related
septicaemia (26). ]’he use of AgNO3 was associated with reduced mortality (27). In common with
other topical antibiMics of the time, there were problems. The particular problem of silver nitrate was
that the hypotor:ic solution caused electrolyte alterations which had to be treated with
supplementary calcium, sodium and potassium (28). This led Fox (29) to develop silver sulfadiazine,
a water insoluble salt which dissolves only slowly in biological fluids. The intention was that low
concentrations of Ag+ would be attained, chloride would not be readily precipitated and antibacterial
activity would be maintained. Controlled trials confirmed its usefulness (77) and it is now the
treatment of choice.
Sulfadiazine is a sulfonamide and is itself an antibiotic. However, the sulfonamide antagonist para-
aminobenzoic acid did not inactivate silver sulfadiazine (AgSu) (30). Further evidence that the silver
was the active component came from the observation that sulfadiazine alone was ineffective at
concentrations at which AgSu inhibited bacterial growth (31,43). Indeed, sulfadiazine exhibited
specific synergism in combination with subinhibitory levels of AgSu (31), which suggests that the
two agents kill bacteria by different mechanisms. Furthermore, Ag resistant bacteria from AgSu
treated burns are not necessarily Su resistant, nor vice versa (31,81). Binding experiments provided
circumstantial evidence for the importance of silver. At inhibitory concentrations of Ag35Su or
468J.L. Clement and P.S. Jarrett Metal Based Drugs
110mAgSu up to 20% of the radioactive silver was bound by cultured cells, whereas the uptake of
radiolabelled sulfadiazine was negligible (32). Incubations of AgSu with NaCI, nutrient broth, DNA,
human serum and bacteria provided experimental support for the hypothesis that AgSu provided
slow sustained delivery of Ag (31). Some salts, such as AgNO3, dissolved immediately and the silver
would be ’lost’ as AgCI or other precipitates. Others showed negligible dissociation over 40 hours,
releasing very little silver, while AgSu dissociated at an intermediate rate and maintained a roughly
constant concentration of silver (31).
ComDlexation of silver bv bioloaical molecules
The stability of silver(I) complexes varies with the ligand donor atom: N<<P>As>Sb; O<<S~Se~Te;
F<Ci<Br<I and Ag(I) has been categorized as a class b or ’soft’ acid (33). Although it binds most
strongly to P and S donor ligands, it has an extensive chemistry with N (in particular) and O
donors(33), and appears to bind to almost every biological molecule tested. Silver(I) has long been
known to form complexes with amino acids (33). It is used to stain proteins in polyacrylamide gels,
being particularly useful when small amounts of protein need to be detected since it is more
sensitive than techniques based on Coomassie Blue. When vadous polyamino acids were tested,
polyhistidine stained the most deeply (34). In certain proteins, silver has been shown to bind at
specific sites" forming Ag6, Ag12 and Ag18 clusters with a rabbit metallothionein (35) and displacing
Cu(I) from its binding site in reduced azudn from Ps. aeruginosa (36).
Given the propensity of silver(I) to complex with so many molecules, it is obviously important to
consider what interactions may occur between the medium and added AgNO3. Decreased
bactedocidal activity in certain media was observed by those working on water sterilization (10,11,12)
(see above), and the effects of different nutrient media have been specifically investigated (37).
Three common agar media differed in their capacity to reduce the bacteriostatic effects of AgNO3.
Since broth and agar forms did not differ, the effect was attributed to soluble compounds of the
media rather than the agar (37). Two silver(I) phosphine complexes exhibited antifungal activity in a
"defined" medium, which was lost in a "complex" medium (38), and the toxicity of one of these
complexes toward tumour cells in vitro was reduced by a factor of five by the presence of foetal calf
serum in the medium. These effects were attributed to reaction with serum proteins and other
components of the media (38). The component which has given rise to the most comment is
chloride, frequently present at up to 171mM (10gl"1 of NaCI) in nutrient broths. The effects of
chloride will be discussed in more detail below.
Silver(I) also forms complexes with some nucleosides and nucleotides at neutral pH (probably
binding at N-7 of the purine base) (39), with RNA (40), and with DNA (31,41,42). Most such
experiments utilise AgNO3. Rosenkranz and Rosenkranz (42) compared the interactions of AgNO3
and AgSu with DNA and concluded that they were different. One of the effects of Ag(I) binding to
DNA is to increase the sedimentation coefficient (41,42). Wysor and Zollinhofer (43) reported that
the sedimentation coefficient of DNA from Ps. aeruginosa treated with AgSu was increased relative
to DNA from untreated bacteria, while Rosenkranz and Carr (44) found no such difference in the
DNA from their treated and untreated Ps. aeruginosa. They further reported that bacteria deficient in
DNA polymerase were not more sensitive to AgSu than was the parent strain (44). Fox, however,
continued to emphasise the importance of DNA binding. In a series of experiments using
radiolabelled silver and sulfadiazine (35S) he showed that only the Ag from AgSu became
associated with isolated DNA (31). Using very low concentrations of AgSu, sufficient only to delay
rather than prevent growth, he found that Ag binding to RNA and cell residue (proteins and
polysacchaddes) rose to a maximum, then stayed stable up to 4 hours. In contrast, binding to DNA
reached a maximum and then decreased again (32). This decrease seemed to coincide with the
resumption of bacterial growth. Since this work there has been very little interest in silver interactions
with nucleic acids.
Localization of silver in cells.
In his experiments treating Ps. aeruginosa with sublethal concentrations of AgSu, Fox found that
less than 0.5% of the silver was in the lipid fraction, up to 3% in the RNA fraction, up to 12% in the
DNA fraction and the remainder was bound to the cell "residue" (proteins and polysaccharides) (32).
Similar observations have been made by many other workers. Rosenkranz and Carr found that most
silver was associated with the cell membrane (and proteins), and some with the cell wall (43). They
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further examined AgSu treated bacteria by electron microscopy, and observed them to be distorted
in shape, with surface blebs (45). A strain resistant to AgSu did not display surface blebs. The same
was true of sensitive and resistant Enterobacter cloacae (66). AgNO3 caused aggregation of nuclear
material, but no blebbing (45). Longer exposures, however, did cause blebbing (46).
Binding of silver by bacteria is also of interest to those hoping to recover metals from industrial
effluents and waste materials (47,48,49) or by leaching from minerals (50) (Table I). Such workers
have also looked at the localization of silver, but usually treat the bacteria with much more
concentrated solutions than the AgSu work referred to above (mM rather than M). The distribution
of silver in Citrobacter intermedius was 5% in the cytoplasm, about 27% in the cell membrane and
about 68% in the cell wall fraction (49); electron micrographs showed large electron dense granules
associated with the cell envelope (49). Thiobacilli collected from sulphide leaching systems were
also covered with electron-dense granules (50). Microprobe analysis showed they contained silver
and sulphur, and electron diffraction suggested the mineral acanthite (Ag2S) (50). This result may
have been very particular to this system, since the electron-dense particles of a silver resistant
pseudomonad (treated with ca. 0.6 mM AgNO3) were not Ag2S nor AgCI as demonstrated by
energy-dispersive X-ray detection (51). The author suggested Ag(0), Ag(I) or silver oxide. Blebbing
was not reported at these concentrations.
Although most silver is undoubtedly associated with the cell wall, the membrane and proteinaceous
cellular appendages (pilae, flagellae), it is difficult to establish the relative importance of this binding.
110Ag from AgNO3 could not be washed off Ps. aeruginosa using nutdent broth, but 0.1% AgNO3
completely removed it (60). Hughes and coworkers (53) have described two types of binding sites:
a low capacity, high affinity binding site (probably intracellular) from which Ag+ is not released by acid
washing, and higher capacity, lower affinity sites (probably on the surface) from which Ag+ is
released by acid washing. They suggest Ag+ is taken up in a metabolism-independent process and
bound at specific intracellular sites. Saturation of these allows surface binding of Ag+.
The consensus seems to be that surface binding and damage to membrane function are important in
the killing of bacteria by silver. This is to some extent supported by reports of the metabolic effects
of silver(I). It inhibits several oxidative enzymes (61), yeast alcohol dehydragenase (62), the uptake
of succinate by membrane visicles (63) and the respiratory chain of E. coli, although this last has
since been suggested to be due to the nitrate counter ion (65). It is also reported to cause
metabolite efflux (83). The early workers on AgSu were particularly interested in macromolecular
synthesis: it was reported both that protein, RNA and DNA syntheses are blocked in AgSu treated
bacteda (44) and that protein and nucleic acid syntheses are not inhibited in cell free systems (43).
Bacterial Resistance to Silver
The widespread use of AgSu led inevitably to the isolation of silver resistant bacteria from burn units
(Table I1. Some reports of silver resistance are not included in the table (75-80)). This was
unwelcome to both physicians and their patients; three of the first cases to be described died after
infection by a multiply resistant Salmonella typhimurium (67). There have been some encouraging
observations, however. Resistance is often reported to be unstable or difficult to maintain
(70,74,79) and is also difficult to transfer (67,78). Although it could be transferred (at very low
frequency" 10-6-10-5) from the S. typhimurium (67) mentioned above, a further 13 strains from the
same laboratory were not able to donate resistance (69). Resistance was only transferred from Ps.
stutzed AG259 when mobilized by a conjugative plasmid (52). It was not transferred from E. coil R1
(55) nor three other resistant E. coil (57) by membrane filter mating, nor from E. coil R1 by artificial
competence, high-voltage electroporation nor plasmid mobilization (57). It was eventually
transferred to E. coil C600 using a Tn5-Mob transposon (59). High-voltage electroporation
succeeded in transferring resistance from Ps. stutzeriAG259 to Ps. putida CYM318 (58). Membrane
filter mating was sufficient to transfer resistance from Acinetobacter baumanii to an E. coli K12, and
thence to another E. coil K12, but at frequencies of only about I x 10-6 in each case (74). Levels of
resistance in recipient bacteda have been reported as lower than those for the donor (67).
The frequency of occurrence of silver resistance seems variable: 2 (probably the same strain) out of
72 Enterobacter species (66); 3 isolates (same strain) out of 19 salmonellae; zero out of 154 E. coli
(67); 5 out of 168 Klebsiellae and 6 out of 119 Enterobacter species (67); 14 out of 1000 isolates
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Table Accumulation of silver by bacteria
Organism Silver accumulated (mg)
by dry weight of bacteria (g)
Reference
Ps. maltophilia, Staphylococcus aureus
and a coryneform organism
>300 47
Thiobacillus ferrioxidans and T. thiooxidans 250 5O
Pseudomonad 300-390 51
Ps. stutzeri AG259 52
Unidentified 48
Escherichia coli 67 53
Citrobacter intermedius 28 (growing)
44(non-growing)
49
Ps. stutzeri AG259
Escherichia coli R1 and S1
Coryneform organism
0.8
390-2,500
2,000
54
55
56
Eschedchia coli R1
Escherichia coil S1
2
12
57
Ps. stutzeriAG259
Ps. putida CYM318(+pKK1
1,170
2,000
58
E. co//R1 and C600(pJT1, PJT2)
E. coli C600
2,700-3,100
7,300
59
amg/g cell protein
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JLB Bacteria reported to be resistant to slivera
Organism (number of strains)
resistant strain(s)
Enterobacter cloacae, vs. AgSuc >1.1 mM
Salmonella typhimuriurnd 10 mM
Enterobacter sp. (7) 5 20 mM
Klebsie//a sp. (5) 5 20 mM
Pseudomonas aeruginosa 5 mM
Escherichla coil (13)
Enterobacter cloacae (4)
Klebsiella pneumonlae (8)
Proteus mlrabiPs
0.25- >5 mM
0,5- 5 mM
0.5 5 mM
0.25 mM
E.col# J62 (+/-pSC35), vs. AgSu
E.coli J62 (+/-pSC35), vs. AgNO3, no CI"
E.cofiJ62 (:1:pSC35), vs. AgNO3, with CI"
~6
~4 #M
> 50 IM
Pseudomonas (4) >0.6 mM
Ps. stutzerid AG259 and AG256, with CI"
Ps. stutzefi AG259 and AG256, no CI"
>25 mM
0.8 mM
K. pneumonia, with or without CI" >0.5 mM
Ps. putidad CYM318(:l:pKK >0.5 mM
E.colid R1 and $1 (+/-pJT1) >1 mM
E.cohd C600 (+/-pJT1, pJT2) >0.5 mM
Ps. stutzerF AG259 and JM303 >0.5 mM
Acinetobacter baumani# BL88
Silver as AgNO3, unless otherwise stated
MIC minimum inhibitory concentration
AgSu silver sulfadiazine
Identified as containing plasmids.
mM
MICb
sensitive strain(s)
9-14mM
0.6 mM
~0.2M
-.0.4M
~0.4 I.uM
~0.06 mM
0,25 mM
0.25 mM
0.1 mM
>0.05 mM
0.5 mM
~0.1 nM
0.05 mM
References
66
67
69
7O
71
51
52
72
58
55
59
73
74
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(69). These were all from hospitals, mainly burns units. Frequencies in city and hospital sewage
were 0.008-0.028 (percent of total viable count) (69), but were very much higher in film reprocessing
sludge: 94% (69). The other, less commonly studied, sources of silver resistant bacteria are silver
mines (48,52).
The isolation of resistant strains has been enormously useful to experimentalists, as it has allowed
good comparative experiments to be done. The enormous range of figures quoted in Tables and II
undoubtedly reflects differences in experimental procedure and conditions, as well as differences
between bacterial species. Nevertheless it is difficult to understand how such different results can
be given for the same species by the same workers (54,58,55,57) without even commenting on
them. Effects of the medium used have already been mentioned (10,11,12,37,38). A
concentration quoted as the MIC of a sensitive strain in one experiment might kill a resistant strain in
another experiment (Table II), and it is obviously important to compare sensitive and resistant strains
of the same organism under the same conditions in order to uncover real differences.
Possible ResistanCe Mechanisms
Accumulation of metal by bacteda has often been implicitly assumed to be related to resistance to, or
at least "tolerance" of, the metal. Comparisons of silver sensitive and resistant bacteria show that this
is not necessarily so. Silver resistant Kiebsiella pneumoniae took up 3-4 times less silver than the
sensitive strain (72); silver resistant E. coli R1 accumulated 5 times less silver than E. co//$1 (57) (this
could also be seen by energy dispersive X-ray ana!ysis but not by measurements with an Ag+-
specific ion electrode (55)). Transfer of plasmids pJT1 and pJT2 to E. coli C600 conferred
resistance, and the recipient displayed decreased accumulation of Ag (59). Accumulation
behaviour, however, may be species specific. The pattern of silver uptake by resistant
Acinetobacter baumanii (pUP188) differed from that of a transformed E. coli (pUP188), the latter
appearing to take up then efflux silver (74). Ps. putida CYM318, with or without pKK1 from Ps.
stutze A259, demonstrated very similar levels of silver accumulation (58). And Ps. stutzed behaves
differently from all other species studied: electron microscopy and energy-dispersive X-ray analysis
showed dense silver deposits associated with the cell surfaces of silver resistant AG259 but not
silver sensitive JM303 (82). There are some suggestions that bacterial accumulation of silver may be
an energy-dependent process (82,54). This variable pattern of behaviour emphasises the
importance of comparing sensitive and resistant organisms only when they are of the same species.
Many possible mechanisms for bacterial resistance to silver have been proposed, but much work,
mainly by Trevors and co-workers, has failed to produce strong support for any one of them. A
resistant Pseudomonas produced a volatile compound which reduced Ag(I) (51), but when resistant
and sensitive strains of Ps. stutze were compared, their reduct[ve capacities were indistinguishable
(52). Both E. coli R1 and E. coli $1 produced H2S (detected by blackening of lead acetate paper)
(55). When H2S and intracellular acid labile SH were assayed for, in the absence of AgNO3, the
silver resistant E. coli R1 produced >30% more of each than did E. coli $1 (57). The positive control,
E. Coli piP, produced more H2S than E. coli R1, but was sensitive to silver (57). There are many
difficulties and possible interferences in determinations of thiol concentrations (73), but it seemed
that silver resistant P$. stutzeri AG259 produced less H2S but had higher intracellular acid-labile
sulphide levels than silver sensitive Ps. stutze JM303 (73). Blackening of colonies is often
reported (51,52,55,74).
The possibility that resistant strains produced a silver binding protein, which would sequestor the
metal, was investigated. In the range 14-200 kDa no new proteins were detected by SDS-PAGE
from E. co/i R1 (55). Indeed, it seemed to lack two outer membrane proteins found in E. coli $1 (55).
HPLC protein analysis of cell-free extracts showed some low molecular weight fractions were
reduced in concentration when either E. co/i R1 or $1 were grown in the presence of sufficient
silver(I), suggesting it inhibited protein synthesis (57). In addition, in the absence of silver(I), E. coli
R1 lacked several fractions present in E. coli $1, and displayed higher cell surface hydrophobicity
(57). Ps. stutzeri strains produced similar proteins in the absence of silver, but the silver-sensitive
JM303 produced high molecular weight proteins during exposure to silver (73). No 6-8 kDa proteins
(typical of metallothionein) were detected, and none of the proteins contained silver (73). There was
no discernible difference between 31p-NMR spectra of these strains, and intracellular
polyphosphate was not thought to be involved in binding silver (73). Some authors have suggested
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that silver may be toxic by more than one mechanism (83), and that there may be more than one
system of resistance (72).
A particularly interesting aspect of the influence of the testing medium has been highlighted by
Simon Silver. The presence of chloride reduces the toxicity of silver only to resistant strains, not to
sensitive ones (71) (Table II). Although NaCI was reported not to affect the sensitivity of K.
pneumoniae (72), the elfect has been confirmed by other workers (52,54,66) and in our own work
(see below). It has been hypothesized that resistant strains cannot compete with AgCI lor the silver
(71). This would seem to agree with the observation that most resistant strains accumulate less silver
than their sensitive counterparts, and perhaps with resistant strains lacking outer membrane
proteins, as found by Trevors and co-workers (57,73). It may also help in understanding the
variability in older work with mixtures of bacteria: only the resistant components would be affected by
the concentration of chloride. AgSu toxicity seems less affected by chloride than AgNO3 toxicity
(71), but both can be affected by the presence of bovine serum albumin, with resistant and sensitive
strains of E. coli again responding differently (84).
A turther complicating factor is the concentration of copper, likely to be an impurity in growth media at
~0.3mM (53). Growth of E. coli K12 was lound to be dependent on the Ag/Cu ratio, rather than
concentration of Ag+ alone (53) and accumulation of silver was also affected by the presence of
copper (53,54). That Ag(I) can displace Cu(I) from its binding site in azurin has already been
mentioned (36).
Physical and Chemical Pro.erties of Silver Com.Dle.xes
The structure of crystalline AgSu has been determined from X-ray diffraction experiments (85,86).
Each silver is coordinated to three sulfadiazine molecules, and each sulfadiazine to three silvers, to
form polymeric chains extending through the crystal. As expected for a polymer, it is very insoluble:
the solubility in water at pH 7 is about 0.1 mg/100ml (2.8mM) (87). In addition to pH, the solubility
also depends on ionic strength and the presence of other complexing agents such as NH3 (87).
Polymeric structures and low solubility are extremely common among silver complexes (33). This
makes it difficult to evaluate antibacterial activity experimentally. It is also the mason why therapeutic
use of silver(I) is confined to topical application, and there are no systemic silver(I) antibiotics.
Our approach has been, for the first time, to compare the toxicity of various silver(I) compounds to
silver resistant and silver sensitive strains of the same species, which were otherwise biochemically
identical. This has only become possible in recent years as plasmid bearing strains have been
isolated and characterised. The silver(I) compounds too are well characterised, with known
structures and properties. This permits us to monitor their reactivity and solubility, and to try and
relate their chemical properties to their antibacterial effects. In so doing, we may hope to understand
more about resistance mechanisms, and also discover which types of compound may allow us to
circumvent such systems.
Materla.!s and Methods
Synthesis1
Silver nitrate, 1,2-bis-(diphenylphosphino)ethane (dppe), 1,2-bis(diphenylphosphino)ethene
(dppey), tdphenylphosphine (PPh3) and 2,2’-bipyddine (bipy) were obtained from Alddch Chemical
Co; 1,2-bis(diethylphosphino)ethane (depe) from Strem. The complexes were synthesized by
literature methods (88,89,90) and gave satisfactory elemental analyses and (in the case of the
phosphine complexes) 31p-{1H} NMR spectra.
NMR Measurements
31p-{1H NMR spectra were recorded on a Jeol FX90Q Spectrometer, operating at 36.15 MHz, in 5-
mm tubes and referenced to an external sample of 85% H3PO4. The phosphine complexes were
dissolved in N,N’-dimethylacetamide (DMA), with D20 in a capillary insert as lock. 31 p.{1H} NMR
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spectra were recorded and then additions made of either NaCI (10 mol. equiv.) dissolved in water or
dithiothreitol (DTT) in DMA or sodium J-D-thioglucose dihydrate (NaSGlu, 1 and 3 mol. equiv.)
dissolved in methanol; apart from [Ag(dppey)2]NO3, to which 1 and 1.5 mol. equiv, of thiois were
added. 31 p.{1H} NMR spectra of the solutions were recorded again after the additions, with any
solid precipitates having been removed.
Antibacterial Activity
Escherichia co/i, silver resistant strain pMG101, and E. coil, silver sensitive strain R906, were
obtained from Prof. S. Silver, University of Illinois at Chicago. In 16 tests, the two strains were
biochemically identical. R906 was maintained on agar of composition (g1-1)" Difco casein hydrolysate
peptone (tryptic) ,10; Oxoid agar bacteriological (Agar no. 1), 15; Difco Bacto yeast extract, 5; BDH
NaCI, 0.06 (1 mM). The silver resistant strain pMG101 was maintained on a medium identical except
for the addition of AgNO3(0.068 gl"1, 0.4 mM). Preliminary experiments had established that the
presence of chloride was necessary for a difference in silver sensitivity to be observed between
R906 and pMG101. When the concentration of NaCI was varied between 1 and 40 mM, an
approximately equal concentration of silver as the nitrate salt was required to inhibit growth of
pMG101. The NaCI concentration (1 mM) was chosen so that the concentration of AgNO3 in the
plates could be kept below 1 mM. At these concentrations of AgNO3, there was no precipitation and
the agar plates were not apparently light sensitive.
Compounds for testing were dissolved in DMA, which is miscible with water, apart from
[Ag(bipy)2]NO3.2H20 and 2,2’-bi which were dissolved in methanol. The final solvent
concentrations in the agar plates were 1-2% (v/v) for DMA, 2.5% (v/v) for methanol. Each
experiment included blanks (solvent only, no compound) which showed that DMA and methanol at
these concentrations did not inhibit growth of E. coll.
A suspension of approximately 106 organisms cm-3 (judged by eye) was made up in distilled water
and 50 1 dispensed onto each plate and spread. This inoculum size achieved semi-confluent
growth in the controls. All tests were done in duplicate. The plates were incubated at 37oc for 18
hours, and then examined for growth of colonies. Each experiment was repeated at least once.
AgNO3 at a range of concentrations was included alongside the test compounds in each
experiment.
Results
Apart from bipy, [Ag(bipy)2]NO3 and [Ag(depe)2]NO3, all the compounds turned milky on dilution in
the agar solution. Table III shows the effects of the ligands at different concentrations on growth of
the two strains; Table IV the effects of the complexes. The results for AgNO3 are included
throughout for comparison. Table V summarises the results of the 31 p_{1 H} NMR measurements for
the phosphine complexes. Addition of water alone to DMA solutions of the complexes caused
precipitation from the [Ag(PPh3)2CI and [Ag(PPh3)3CI} solutions, but not from the other silver
phosphine/DMA solutions.
Discussion
From Table III it can be seen that the toxicities (or otherwise) of all the ligands toward the two strains
are the same. This is as expected, since them is no reason to expect a silver resistant strain to show
cross resistance to one of these ligands.
Comparison of the toxicities of the silver complexes of the chelating phosphines, [Ag(dppe)2]NO3,
[Ag(dppeY)2]NO3 and [Ag(depe)2]NO3 toward the two strains (Table IV) shows that there is very
little difference for each of the three complexes. This suggests that the mechanism of toxicity in
these cases is not related to the presence of silver in the complexes. [Ag(dppe)2]NO3 is toxic at
lmM. This corresponds to a dppe concentration of 2mM, which is not toxic under these conditions
(Table III). Similar comparisons can be made for dppey and depe. These show that the effect is not
due to the ligands alone either. Instead, the toxicities of these complexes are likely to be properties
of the complex as a whole. They are hydrophobic cations which are relatively soluble and stable
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(Table V). In common with the Au(I) and Cu(I) analogues they are known to be highly toxic to B16
melanoma and P388 cell lines in vitro (38,91). The mechanism whereby these complexes kill cells is
likely to be the same for all, irrespective of the nature of the metal or the chelating phosphine, except
insofar as these affect solubility and stability of the complex. This has been discussed in detail (91).
Silver(I) complexes of the monodentate phosphine PPh3 behave very differently from their
chelating counterparts. They am more readily precipitated by chloride and less stable to thiols (Table
V). The three tested, [Ag(PPh3)2CI], [Ag(PPh3)3CI] and [Ag(PPh3]NO3] are all more toxic toward
E. coli R906 than is AgNO3 itself. This is not due to toxicity by PPh3, which is non-toxic at these
concentrations (Table III), but is presumably due to availability of Ag+ from the complex. That the
silver is the active component in these cases is shown by their lesser toxicity towards the silver-
resistant E. coli pMG101 (Table IV). The two chloride complexes are even less toxic than AgNO3,
but [Ag(PPh3)NO3] was consistently more toxic than AgNO3. This has the exciting implication that
this complex is in part circumventing the resistance system employed by E. coli pMG101. However,
it is not clear from the chemical properties why this should be so. It was the only one of the PPh3
complexes not precipitated from DMA by water, but the proportions used for the testing plates
caused the agar to appear milky, and it is reported to exchange NO3" for CI" in solution (89).
The bipyridyl complex is in a different category from the others in that the ligand alone is as toxic as
Ag+ is to the sensitive E. coli R906, with an MIC of ~0.4mM. The toxicity of the complex (MIC
~0.2mM) could be due solely to the ligands, since a 0.2mM solution of [Ag(bipy)2]+ is 0.4mM in bipy.
It is also not entirely clear whether them is a difference between the results for the two strains. It is
perhaps not surprising that this complex is bactedocidal, since such activity is already known for bipy
complexes with copper (92) and other metals (10). The activity was at first ascribed to the complex as
a whole, with charge, size and liptophilicity being important factors (93). However, different rates of
bacterial kill by complexes with different metal ions (94) suggested kinetic lability was also important.
This is probably another example of complexes damaging bacteria by more than one mechanism.
These compounds provide good examples of Sadler’s classification (95) of biologically active metal
complexes into ’active complexes’ (silver complexes with diphosphines), ’active metal’ (silver
complexes with PPh3) and ’active ligand’ (silver with bipyridine).
The problem of dissolving silver complexes for testing purposes is rarely discussed. Modak and Fox
(32) did address this. They described dissolving AgSu in 28% ammonia which was then diluted in
the nutrient broth to the required concentration. In control experiments, they found such
ammoniacal solutions did not significantly affect uptake of silver by Ps. aeruginosa and did not alter
cell function (32). In our systems, the amount of ammonia required to solubilise AgSu (to achieve
silver concentrations as shown in the Tables) was toxic to the E. co/i. We also did not proceed with
testing complexes which precipitated in lumps when diluted in the nutrient broth. However, most of
complexes tested did precipitate (see Results) to give homogeneous, milky solutions which were
not light sensitive. This raises the question of what is meant by "concentration" in such systems.
Minimum inhibitory concentrations (MICs) have regularly been quoted for AgSu which are greater
than its solubility of about 3mM (e.g. ref 81) and for silver as the nitrate (see Table II) which are greater
than the solubility of AgCI (about 6mM at 10C (96)). Attempts to measure dissolved silver in testing
systems have found the concentrations to be very low. Belly and Kydd (51), who tabulated
concentrations of 100 and 300ppm as permitting growth of resistant strains, claimed that 300ppm of
AgNO3 gave rise to only 3ppb of ionic silver. Ricketts et al (60) used a silver-specific electrode to
measure [Ag+] at different combinations of added AgNO3 and NaCI. In the range 0.05-0.1M NaCI,
MIC values of added AgNO3 of 0.1-0.2mM corresponded to 1-3 x 10"9M Ag+. The MIC did not
correspond with the measured concentration of silver ions, but with the total amount of silver
available (60). A similar point was made by Fox and Modak (31). They measured the bacterial binding
of silver from supernatant and sediments of human serum which had been reacted with seven
different silver compounds. The amount of silver bound from the supernatants was only 14.5-
18.5%. Much greater amounts were bound from the sediments: 40-58% from four silver
sulfonamides and 74-83% from AgNO3, AgCI and AgSu (31). The implication of all these
observations is that silver is not taken up from solution but from undissolved silver(I) compounds.
This would also seem to be implicit in Simon Silver’s hypothesis regarding the effect of CI- on silver-
resistant cells (71) (see above).
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The problem of understanding the biological effects of nickel(ll) may provide a parallel. Soluble Ni(ll)
salts damaged isolated DNA, but were not carcinogenic. Insoluble, amorphous nickel sulphides
were not carcinogenic either. Insoluble, crystalline, nickel sulphides did transform cells but did not
damage isolated DNA. Finally, Costa showed that crystalline nickel sulphide (which is negatively
charged) is phagocytosed, undergoes cytoplasmic dissolution and the resultant Ni2+(aq) can enter
the nucleus and induce DNA strand breaks (97,98). Amorphous nickel sulphides (negatively
charged) are not phagocytosed, and dissolved Ni2+(aq) cannot enter the cell.
It is clear that our understanding of silver toxicity to bacteria, and of bacterial resistance mechanisms,
has a long way to go. We can be sure that comparative studies of resistant and sensitive strains will
provide the greatest insight. In the meantime, we have identified some silver compounds which are
either toxic by other means, or can circumvent the resistance mechanisms.
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